213.06

0.78% -1.68

West Pharmaceutical Services Inc (WST)

Overview News Price History Option Chain Financials Why WST Down? Discussions Forecast Stock Split Dividend History

West Pharmaceutical Services Inc stock is traded at $213.06, with a volume of 539.20K. It is down -0.78% in the last 24 hours and up +4.68% over the past month. West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Previous Close:

$214.74

Open:

$215.34

24h Volume:

539.20K

Relative Volume:

0.48

Market Cap:

$15.18B

Revenue:

$2.88B

Net Income/Loss:

$499.60M

P/E Ratio:

31.61

EPS:

6.74

Net Cash Flow:

$321.60M

1W Performance:

+0.84%

1M Performance:

+4.68%

6M Performance:

-34.26%

1Y Performance:

-41.72%

1-Day Range:

$212.87

$215.66

1-Week Range:

$204.78

$221.42

52-Week Range:

$187.43

$372.52

West Pharmaceutical Services Inc Stock (WST) Company Profile

Name

West Pharmaceutical Services Inc

Sector

Healthcare (1153)

Industry

Medical Instruments & Supplies (64)

Phone

(610) 594-2900

Address

530 HERMAN O. WEST DRIVE, EXTON, PA

Employee

10,600

Twitter

@WestPharma

Next Earnings Date

2024-10-24

Latest SEC Filings

WST's Discussions on Twitter

Compare WST with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
WST West Pharmaceutical Services Inc	213.06	15.18B	2.88B	499.60M	321.60M	6.74
ISRG Intuitive Surgical Inc	536.51	189.75B	8.71B	2.48B	1.75B	6.82
ALC Alcon Inc	95.75	48.62B	9.91B	1.02B	665.00M	2.05
BDX Becton Dickinson Co	167.22	48.37B	20.87B	1.50B	2.59B	5.24
RMD Resmed Inc	245.04	35.18B	5.02B	1.31B	1.56B	8.91
COO The Cooper Companies, Inc.	82.27	16.46B	3.90B	392.30M	288.10M	1.95

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-18-25	Initiated	Evercore ISI	Outperform
Feb-14-25	Upgrade	Deutsche Bank	Hold → Buy
Jan-08-25	Initiated	Citigroup	Buy
Dec-13-24	Initiated	Wolfe Research	Peer Perform
Dec-12-24	Upgrade	UBS	Neutral → Buy
Feb-07-24	Upgrade	Jefferies	Hold → Buy
Jun-16-23	Upgrade	BofA Securities	Neutral → Buy
Apr-11-23	Upgrade	Stephens	Equal-Weight → Overweight
Dec-14-22	Initiated	Deutsche Bank	Hold
Nov-30-22	Initiated	UBS	Neutral
Oct-28-22	Downgrade	BofA Securities	Buy → Neutral
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Oct-14-20	Initiated	Stephens	Equal-Weight
Jul-21-20	Upgrade	BofA Securities	Neutral → Buy
Apr-24-20	Upgrade	BofA/Merrill	Underperform → Neutral
Dec-12-19	Downgrade	BofA/Merrill	Neutral → Underperform
Jul-26-19	Upgrade	BofA/Merrill	Underperform → Neutral
May-01-19	Downgrade	Jefferies	Buy → Hold
Apr-23-19	Initiated	William Blair	Outperform
Apr-25-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jan-24-18	Initiated	Goldman	Neutral
Oct-17-17	Downgrade	BofA/Merrill	Buy → Neutral
Oct-03-17	Initiated	Stephens	Equal-Weight
Sep-15-17	Upgrade	Jefferies	Hold → Buy
Oct-28-16	Upgrade	Wells Fargo	Market Perform → Outperform
Sep-21-16	Downgrade	Wells Fargo	Outperform → Market Perform
Mar-22-16	Initiated	Wells Fargo	Outperform
May-14-10	Reiterated	UBS	Neutral
Feb-23-10	Initiated	Jefferies & Co	Buy
Dec-19-08	Initiated	UBS	Neutral

View All

West Pharmaceutical Services Inc Stock (WST) Latest News

May 09, 2025

West Pharmaceutical announces shareholder voting results - Investing.com Australia

May 09, 2025

WST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire

May 09, 2025

Levi & Korsinsky Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025WST - ACCESS Newswire

May 09, 2025

West Pharmaceutical Services, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before July 7, 2025 to Discuss Your RightsWST - ACCESS Newswire

May 09, 2025

Levi & Korsinsky Notifies Shareholders of West Pharmaceutical Services, Inc.(WST) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

May 09, 2025

May 08, 2025

Class Action Filed Against West Pharmaceutical Services, Inc. (WST)July 7, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

May 08, 2025

WEST PHARMACEUTICAL ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire

May 08, 2025

WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar

May 08, 2025

West Pharmaceutical Services Hosts 2025 Shareholder Meeting - TipRanks

May 08, 2025

West Pharmaceutical announces shareholder voting results By Investing.com - Investing.com South Africa

May 08, 2025